MedPath
HSA Approval

Posicaine-100 Injection

SIN14537P

Posicaine-100 Injection

Posicaine-100 Injection

April 10, 2014

N.K. LUCK (S) PTE LTD

N.K. LUCK (S) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantN.K. LUCK (S) PTE LTD
Licence HolderN.K. LUCK (S) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

DENTAL

Medical Information

N01BB58

articaine, combinations

Manufacturer Information

n.k. luck (s) pte ltd

Novocol Pharmaceutical of Canada Inc.

Active Ingredients

Epinephrine Bitartrate 0.018mg/ml eqv Epinephrine

0.01mg/ml

Epinephrine

Articaine HCl

40mg/ml

Articaine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Posicaine-100 Injection - HSA Approval | MedPath